1 / 4
Tesamorelin is indicated for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy.
The recommended dose of Tesamorelin is 2 mg injected subcutaneously (under the skin) into the abdomen once a day.
Tesamorelin is indicated for the reduction of excess abdominal fat in HIV-infected adult patients who suffer from lipodystrophy.
The standard recommended dosage is 2 mg once daily.
It should be injected subcutaneously (under the skin) directly into the abdomen once a day.
Clinical observations show that it leads to both reduced visceral abdominal fat and reduced liver fat.
Tesamorelin supports significant IGF-1 increases, improved cardiovascular health, and reduced LDL cholesterol levels.
Yes, it aids in increasing muscle mass and accelerating recovery time after physical workouts.
